"Henry Ford Medical Center - Columbus, provides primary care, behavioral health, cancer treatment, diabetes, gastroenterology, infusion, radiology and rehabilitation services. Specialty services include MOHs surgery, MRIs, and a travel clinic. This location also offers walk-in primary care services for the cost of a primary care doctor office visit seven days a week and on holidays. Walk-in services include common health issues as deep cuts, minor bone fractures, sprains, bladder infection, cough, earache, fever, and sore throat. At the intersection of 12 Mile and Haggerty roads."

During the past decade, Henry Ford Medical Center-Columbus conducted 87 clinical trials. In the 10-year time frame, 87 clinical trials started and 21 clinical trials were completed, i.e. on average, 24.1% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 18 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Henry Ford Medical Center-Columbus" #1 sponsor was "National Cancer Institute (NCI)" with 42 trials, followed by "SWOG Cancer Research Network" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "NRG Oncology" with 8 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Henry Ford Medical Center-Columbus" #1 collaborator was "National Cancer Institute (NCI)" with 43 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "University of Michigan" with 3 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Henry Ford Medical Center-Columbus" are "Chronic Lymphocytic Leukemia" (4 trials), "Insomnia" (4 trials), "Invasive Breast Carcinoma" (4 trials), "Recurrent Breast Carcinoma" (4 trials) and "Recurrent Ovarian Carcinoma" (4 trials). Many other conditions were trialed in "Henry Ford Medical Center-Columbus" in a lesser frequency.

Most popular intervention types in "Henry Ford Medical Center-Columbus" are "Drug" (77 trials), "Other" (52 trials), "Biological" (41 trials), "Procedure" (27 trials) and "Radiation" (11 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (24 trials), "Laboratory Biomarker Analysis" (23 trials), "Biospecimen Collection" (19 trials), "Computed Tomography" (17 trials) and "Nivolumab" (16 trials). Other intervention names were less common.

The vast majority of trials in "Henry Ford Medical Center-Columbus" are 90 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Henry Ford Medical Center-Columbus". undefined are not yet recruiting, 36 are recruiting, 49 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Henry Ford Medical Center-Columbus, 3 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Henry Ford Medical Center-Columbus, 4 "Phase 1" clinical trials were conducted, 45 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".